Literature DB >> 19544289

Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats.

Xinyu Wang1, Jihai Pang, Jacqueline A Maffucci, Devendra S Pade, Robert A Newman, Sean M Kerwin, Phillip D Bowman, Salomon Stavchansky.   

Abstract

The pharmacokinetic profiles of caffeic acid phenethyl ester (CAPE) and its catechol-ring fluorinated derivative (FCAPE) were determined in rats after intravenous administration of 5, 10 or 20 mg/kg for CAPE and 20 mg/kg for FCAPE, respectively. The plasma concentrations of CAPE and FCAPE were measured using a validated liquid chromatography tandem mass spectrometric method. The pharmacokinetic parameters were estimated using non compartmental analysis (NCA) and biexponential fit. The results showed that the area under the plasma concentration-time curve for CAPE treatment increased in a proportion greater than the increase in dose from 5 to 20 mg/kg of CAPE. Total body clearance values for CAPE ranged from 42.1 to 172 ml/min/kg (NCA) and decreased with the increasing dose of CAPE. Similarly, the volume of distribution values for CAPE ranged from 1555 to 5209 ml/kg, decreasing with increasing dose. The elimination half-life for CAPE ranged from 21.2 to 26.7 min and was independent of dose. That FCAPE was distributed extensively into rat tissues and eliminated rapidly was indicated by a high value of volume of distribution and similar short elimination half-life as that of CAPE. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544289     DOI: 10.1002/bdd.657

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  16 in total

1.  Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis.

Authors:  Bonnie Williams; Eleni Tsangari; Romany Stansborough; Victor Marino; Melissa Cantley; Anak Dharmapatni; Rachel Gibson; Egon Perilli; Tania Crotti
Journal:  Inflammopharmacology       Date:  2017-01-03       Impact factor: 4.473

2.  The possible preventive effect of caffeic acid phenethyl ester (CAPE) against myringosclerosis.

Authors:  Haci Kemal Erdemli; Sumeyya Akyol; Ferah Armutcu; Omer Akyol
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-24       Impact factor: 2.503

3.  Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects (Review).

Authors:  Ferah Armutcu; Sumeyya Akyol; Seyfettin Ustunsoy; Fatime Filiz Turan
Journal:  Exp Ther Med       Date:  2015-03-11       Impact factor: 2.447

Review 4.  Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy.

Authors:  Victor Emanuel Miranda Soares; Thiago Inácio Teixeira do Carmo; Fernanda Dos Anjos; Jonatha Wruck; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini; Débora Tavares de Resende E Silva
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

5.  Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.

Authors:  Hui-Ping Lin; Ching-Yu Lin; Chieh Huo; Ping-Hsuan Hsiao; Liang-Cheng Su; Shih Sheng Jiang; Tzu-Min Chan; Chung-Ho Chang; Li-Tzong Chen; Hsing-Jien Kung; Horng-Dar Wang; Chih-Pin Chuu
Journal:  Oncotarget       Date:  2015-03-30

Review 6.  Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer.

Authors:  Ying-Yu Kuo; Wai-Tim Jim; Liang-Cheng Su; Chi-Jung Chung; Ching-Yu Lin; Chieh Huo; Jen-Chih Tseng; Shih-Han Huang; Chih-Jen Lai; Bo-Chih Chen; Bi-Juan Wang; Tzu-Min Chan; Hui-Ping Lin; Wun-Shaing Wayne Chang; Chuang-Rung Chang; Chih-Pin Chuu
Journal:  Int J Mol Sci       Date:  2015-05-12       Impact factor: 5.923

7.  Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in MCF-7 Breast Cancer Cells.

Authors:  Tarek K Motawi; Samy A Abdelazim; Hebatallah A Darwish; Eman M Elbaz; Samia A Shouman
Journal:  Oxid Med Cell Longev       Date:  2015-11-30       Impact factor: 6.543

8.  New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.

Authors:  Luc H Boudreau; Grégoire Lassalle-Claux; Marc Cormier; Sébastien Blanchard; Marco S Doucet; Marc E Surette; Mohamed Touaibia
Journal:  Mediators Inflamm       Date:  2017-06-07       Impact factor: 4.711

9.  Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling.

Authors:  Hui-Ping Lin; Ching-Yu Lin; Chun-Chieh Liu; Liang-Cheng Su; Chieh Huo; Ying-Yu Kuo; Jen-Chih Tseng; Jong-Ming Hsu; Chi-Kuan Chen; Chih-Pin Chuu
Journal:  Int J Mol Sci       Date:  2013-03-06       Impact factor: 5.923

Review 10.  Antiviral properties of caffeic acid phenethyl ester and its potential application.

Authors:  Hacı Kemal Erdemli; Sumeyya Akyol; Ferah Armutcu; Omer Akyol
Journal:  J Intercult Ethnopharmacol       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.